GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapport Therapeutics Inc (NAS:RAPP) » Definitions » Net Margin %

RAPP (Rapport Therapeutics) Net Margin % : 0.00% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Rapport Therapeutics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Rapport Therapeutics's Net Income for the three months ended in Dec. 2024 was $-19.98 Mil. Rapport Therapeutics's Revenue for the three months ended in Dec. 2024 was $0.00 Mil. Therefore, Rapport Therapeutics's net margin for the quarter that ended in Dec. 2024 was 0.00%.

The historical rank and industry rank for Rapport Therapeutics's Net Margin % or its related term are showing as below:


RAPP's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -114.45
* Ranked among companies with meaningful Net Margin % only.

Rapport Therapeutics Net Margin % Historical Data

The historical data trend for Rapport Therapeutics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapport Therapeutics Net Margin % Chart

Rapport Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
Net Margin %
- - -

Rapport Therapeutics Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Margin % Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Rapport Therapeutics's Net Margin %

For the Biotechnology subindustry, Rapport Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rapport Therapeutics's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapport Therapeutics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Rapport Therapeutics's Net Margin % falls into.


;
;

Rapport Therapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Rapport Therapeutics's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-78.307/0
= %

Rapport Therapeutics's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-19.98/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rapport Therapeutics  (NAS:RAPP) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Rapport Therapeutics Net Margin % Related Terms

Thank you for viewing the detailed overview of Rapport Therapeutics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Rapport Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
1325 Boylston Street, Suite 401, Boston, MA, USA, 02215
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.